My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 641

    1.

    Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.

    Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG.

    Ann Intern Med. 2005 Dec 20;143(12):870-80.PMID: 16365468 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

    Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, Vimalachandra D, Webster AC.

    Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003774. Review. Update in: Cochrane Database Syst Rev. 2008;(2):CD003774. PMID: 16235341 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

    Strippoli GF, Hodson EM, Jones CJ, Craig JC.

    Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005133. Review.PMID: 16437521 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

    Hodson EM, Craig JC, Strippoli GF, Webster AC.

    Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003774. Review.PMID: 18425894 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.

    Strippoli GF, Hodson EM, Jones C, Craig JC.

    Transplantation. 2006 Jan 27;81(2):139-45. Review.PMID: 16436954 [PubMed - indexed for MEDLINE]Related articles

    6.

    Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

    Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC.

    Lancet. 2005 Jun 18-24;365(9477):2105-15. Review.PMID: 15964447 [PubMed - indexed for MEDLINE]Related articles

    7.

    WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.

    Couchoud-Heyer C.

    Cochrane Database Syst Rev. 2007 Jul 18;(4):CD001320. Review.PMID: 17636667 [PubMed - indexed for MEDLINE]Related articles

    8.

    Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.

    Hodson EM, Jones CA, Strippoli GF, Webster AC, Craig JC.

    Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005129. Review.PMID: 17443573 [PubMed - indexed for MEDLINE]Related articles

    9.

    Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.

    Small LN, Lau J, Snydman DR.

    Clin Infect Dis. 2006 Oct 1;43(7):869-80. Epub 2006 Aug 23.PMID: 16941368 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cytomegalovirus infection after liver transplantation: current concepts and challenges.

    Razonable RR.

    World J Gastroenterol. 2008 Aug 21;14(31):4849-60. Review.PMID: 18756591 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

    Noble S, Faulds D.

    Drugs. 1998 Jul;56(1):115-46. Review.PMID: 9664203 [PubMed - indexed for MEDLINE]Related articles

    12.

    Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy.

    Kalil AC, Freifeld AG, Lyden ER, Stoner JA.

    PLoS One. 2009;4(5):e5512. Epub 2009 May 13.PMID: 19436751 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

    Kusne S, Shapiro R, Fung J.

    Transpl Infect Dis. 1999 Sep;1(3):187-203. Review.PMID: 11428989 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy.

    Baillie GM.

    Am J Health Syst Pharm. 2006 Oct 1;63(19 Suppl 5):S10-6. Review.PMID: 16990639 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies]

    Varga M, Remport A, Czebe K, Péter A, Toronyi E, Sárváry E, Fehérvári I, Sulyok B, Járay J.

    Orv Hetil. 2008 Mar 23;149(12):551-8. Review. Hungarian. PMID: 18343771 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.

    Couchoud C.

    Cochrane Database Syst Rev. 2000;(2):CD001320. Review. Update in: Cochrane Database Syst Rev. 1998;(4):CD001320. PMID: 10796773 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antifungal agents for preventing fungal infections in solid organ transplant recipients.

    Playford EG, Webster AC, Sorell TC, Craig JC.

    Cochrane Database Syst Rev. 2004;(3):CD004291. Review.PMID: 15266524 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cytomegalovirus in transplantation - challenging the status quo.

    Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME.

    Clin Transplant. 2007 Mar-Apr;21(2):149-58. Review.PMID: 17425738 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]

    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.

    Rev Invest Clin. 2002 May-Jun;54(3):198-203. Spanish. PMID: 12183888 [PubMed - indexed for MEDLINE]Related articles

    20.

    Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.

    Len O, Gavaldà J, Aguado JM, Borrell N, Cervera C, Cisneros JM, Cuervas-Mons V, Gurguí M, Martin-Dávila P, Montejo M, Muñoz P, Bou G, Carratalà J, Torre-Cisneros J, Pahissa A; RESITRA.

    Clin Infect Dis. 2008 Jan 1;46(1):20-7.PMID: 18171208 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...